Creation of a hemophilia B mouse expressing defective human factor IX

被引：0
|
作者：
Monahan, PE [1 ]
Zhang, TP [1 ]
Jin, DY [1 ]
Gui, T [1 ]
Stafford, DW [1 ]
机构：
[1] Univ N Carolina, Chapel Hill, NC USA
来源：
MOLECULAR THERAPY | 2004年 / 9卷
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
31
引用
收藏
页码：S13 / S13
页数：1
相关论文
共 50 条
  • [31] Influence of Obesity on Factor IX Expression after Gene Therapy in a Mouse Model of Hemophilia B
    Coulibaly, Sogue
    Weiller, Markus
    Bauer, Alexander
    Lengler, Johannes
    Romeder-Finger, Stefan
    Kopic, Alexandra
    Benamara, Karima
    Monahan, Paul
    Rottensteiner, Hanspeter
    Scheiflinger, Friedrich
    Turecek, Marietta
    Hoellriegl, Werner
    BLOOD, 2017, 130
  • [32] Treatment of a Hemophilia B Mouse Model with Platelet-Targeted Expression of Factor IX Padua
    Li, Binbin
    Wu, Zhihan
    Xu, Wenjue
    Han, Wenwen
    Liu, Jiayu
    Wang, Dawei
    Zhang, Guowei
    HUMAN GENE THERAPY, 2021, 32 (9-10) : 506 - 516
  • [33] A HIGHLY PURIFIED HUMAN FACTOR-IX CONCENTRATE FOR THE THERAPY OF HEMOPHILIA-B
    SUOMELA, H
    HAMALAINEN, E
    AHO, L
    THROMBOSIS AND HAEMOSTASIS, 1991, 65 (06) : 1158 - 1158
  • [34] Optimized human factor IX expression cassettes for hepaticdirected gene therapy of hemophilia B
    Ru Zhang
    Qiang Wang
    Lin Zhang
    Saijuan Chen
    Frontiers of Medicine, 2015, 9 (01) : 90 - 99
  • [35] Extravascular administration of factor IX: Potential for replacement therapy of canine and human hemophilia B
    Liles, D
    Landen, CN
    Monroe, DM
    Lindley, CM
    Read, MS
    Roberts, HR
    Brinkhous, KM
    THROMBOSIS AND HAEMOSTASIS, 1997, 77 (05) : 944 - 948
  • [36] Factor IX-Triple, an improvement upon natural factor IX for treating hemophilia B?
    Lin, S-W
    Kao, C-Y
    Lin, C-N
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 500 - 500
  • [37] Kinetics of factor IX activity differ from that of factor IX antigen in patients with hemophilia B
    RosenwaldZuckerman, T
    Yasmin, S
    Retzios, A
    Kasper, CK
    Leibman, HA
    BLOOD, 1995, 86 (10) : 3531 - 3531
  • [38] Permanent partial phenotypic correction and tolerance in a mouse model of hemophilia B by stem cell gene delivery of human factor IX
    B W Bigger
    E K Siapati
    A Mistry
    S N Waddington
    M S Nivsarkar
    L Jacobs
    R Perrett
    M V Holder
    C Ridler
    G Kemball-Cook
    R R Ali
    S J Forbes
    C Coutelle
    N Wright
    M Alison
    A J Thrasher
    D Bonnet
    M Themis
    Gene Therapy, 2006, 13 : 117 - 126
  • [39] Recombinant human factor IX: Replacement therapy, prophylaxis, and pharmacokinetics in canine hemophilia B
    Brinkhous, KM
    Sigman, JL
    Read, MS
    Stewart, PF
    McCarthy, KP
    Timony, GA
    Leppanen, SD
    Rup, BJ
    Keith, JC
    Garzone, PD
    Schaub, RG
    BLOOD, 1996, 88 (07) : 2603 - 2610
  • [40] Permanent partial phenotypic correction and tolerance in a mouse model of hemophilia B by stem cell gene delivery of human factor IX
    Bigger, BW
    Siapati, EK
    Mistry, A
    Waddington, SN
    Nivsarkar, MS
    Jacobs, L
    Perrett, R
    Holder, MV
    Ridler, C
    Kemball-Cook, G
    Ali, RR
    Forbes, SJ
    Coutelle, C
    Wright, N
    Alison, M
    Thrasher, AJ
    Bonnet, D
    Themis, M
    GENE THERAPY, 2006, 13 (02) : 117 - 126
12345